REGENXBIO Inc. Operating Lease, Payments
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-05
- REGENXBIO Inc. operating lease, payments for the quarter ending 2020-09-30 was $988.00K, a 30.52% increase year-over-year.
- REGENXBIO Inc. operating lease, payments for the quarter ending 2019-12-31 was $572.00K.
- REGENXBIO Inc. operating lease, payments for the quarter ending 2019-09-30 was $757.00K.
- REGENXBIO Inc. operating lease, payments for the quarter ending 2019-06-30 was $684.00K.
- REGENXBIO Inc. operating lease, payments for fiscal 2025 was $13.07M, a 0.79% increase from fiscal 2024.
- REGENXBIO Inc. operating lease, payments for fiscal 2024 was $12.97M, a 9.34% increase from fiscal 2023.
- REGENXBIO Inc. operating lease, payments for fiscal 2023 was $11.86M, a 108.20% increase from fiscal 2022.
- REGENXBIO Inc. operating lease, payments for fiscal 2022 was $5.70M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $13.07M 10-K · filed 2026-03-05 | |||
| 2024-12-31 | $12.97M 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $11.86M 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $5.70M 10-K · filed 2025-03-13 | |||
| 2020-09-30 | $988.00K 10-Q · filed 2020-11-04 | $2.48M 10-Q · filed 2020-11-04 | ||
| 2019-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.33M derived: sum of 2 quarters · filed 2020-02-26 | $2.01M derived: sum of 3 quarters · filed 2020-02-26 | $2.72M 10-K · filed 2020-02-26 |
| 2019-09-30 | $757.00K 10-Q · filed 2019-11-05 | $1.44M derived: sum of 2 quarters · filed 2019-11-05 | $2.15M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $684.00K 10-Q · filed 2019-08-07 | $1.40M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $711.00K 10-Q · filed 2019-05-07 |